We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
Some pharmacies in northern Mexico that cater to U.S. tourists are selling medications that are laced with fentanyl and methamphetamine, according to a new study.
The $21 billion opioid settlement brokered last year between the three largest U.S. pharmaceutical distributors and the attorneys general of 46 states has made it more difficult for some patients to obtain other types of medications, including those for addiction, anxiety and attention deficit hyperactivity disorder, according to The New York Times.
The Department of Justice this week announced a suit against Rite Aid, alleging the pharmacy chain knowingly filled unlawful prescriptions for controlled substances, including opioids.
A new study finds that opioids were responsible for more than half of all fatal poisonings in children under age 5 in 2018. The rate of fatal opioid poisonings in young children has doubled since 2005, CNN reports.
Some addiction experts are hopeful that more patients will be treated with the opioid use disorder medication buprenorphine now that Congress has made it easier for doctors to prescribe it, NPR reports. But others are concerned stigma could undermine efforts to expand access.
Data from the Food and Drug Administration on its confiscation of packages containing substances coming through international mail shows few of them contain opioids, Kaiser Health News reports. The overwhelming majority of the packages were uncontrolled prescription medications that people had ordered, such as generic Viagra.
View our curated digest of the latest research news, including a study on the impact of childhood trauma on problematic alcohol and drug use trajectories and the moderating role of social support.
The U.S. Food and Drug Administration announced this week it is taking action to restrict illegal importing of the veterinary pharmaceutical xylazine, which has increasingly been found in illicit fentanyl and involved in a growing number of overdose deaths.
The Drug Enforcement Administration is proposing to reinstate federal rules, waived during the pandemic, that require patients to see a doctor in person to receive an initial prescription for controlled medicines such as OxyContin or Adderall.
A new clinical trial will compare the ability of patients to remain in treatment for opioid addiction when prescribed buprenorphine or methadone in an office setting, STAT reports.
View our curated digest of the latest research news, including a study identifying the frequency of medications for opioid use disorder (MOUD) prior authorization prohibitions in state laws.
The federal government will allow states to use Medicaid funds to provide addiction treatment and other medical services for people in state jails and prisons, AP reports.
A new study finds deaths from methamphetamine rose 50-fold between 1999 and 2021 in the United States, HealthDay reports. Many of the deaths also involved heroin or fentanyl.
After a Food and Drug Administration advisory panel voted to make the nasal spray version of the opioid overdose antidote naloxone (Narcan) available without a prescription, experts say the medication’s cost will determine how many people can benefit from it.
Find more of our must-reads in policy news, including the Biden administration's plans to allow Medicaid to cover addiction and other care for people who are incarcerated.
View our curated digest of the latest research news, including a study examining the association between child maltreatment and substance use disorder across emerging adulthood.
The cost of buprenorphine treatment for opioid use disorder decreased from 2015 to 2020, according to a new study. But costs varied widely depending on a patient’s insurance, Axios reports.
View our curated digest of the latest research news, including the association between opioid tapering and subsequent health care use, medication adherence and chronic condition control.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
